genedrive plc (AIM:GDR)

Market Cap	9.51M
Revenue (ttm)	613.00K
Net Income (ttm)	-7.37M
Shares Out	609.81M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,885,102
Average Volume	7,213,480
Open	1.530
Previous Close	1.560
Day's Range	1.523 - 1.550
52-Week Range	1.208 - 7.250
Beta	1.58
RSI	34.70
Earnings Date	Mar 28, 2025

About genedrive

genedrive plc engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications. The company provides c system, rapid nucleic acid thermocycler and fluorescence signal detection system for target discrimination used for qualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a certified test for identification of individuals unlikely to respond to the commonly prescribed antiplatelet drug Cl...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 2000
• Employees: 43
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: GDR

Financial Performance

In 2024, genedrive's revenue was 501,000, an increase of 810.91% compared to the previous year's 55,000. Losses were -7.08 million, 37.4% more than in 2023.